FindTrial
Sign In

What composition of drugs is more efficacious for the suprascapular nerve block given in patients with cervical pain.

To compare the efficacy of suprascapular nerve block using local anaesthetic and two different doses of steroid in cervical radicular pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042711
Enrollment
40
Registered
2022-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M501- Cervical disc disorder with radiculopathy

Interventions

Intervention1: Suprascapular nerve block: Suprascapular nerve block as a single intravenous injection will be given using 2 ml of 0.5% plain bupivacaine and 8mg dexamethasone via anatomical landmark

Sponsors

PtBDSharma PGIMS ROHTAK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling following three criteria will be included in the study: ââ?¬Â¢History, physical examination and pain pattern consistent with cervical radiculopathy. ââ?¬Â¢X-ray cervical spine or MRI findings corresponding with the patientââ?¬•s clinical symptoms. ââ?¬Â¢Failure to respond to six weeks of conservative treatment.

Exclusion criteria

Exclusion criteria: Patients with �History of uncontrolled diabetes mellitus �Active infection or active wound at the suprascapular, cervical and upper limb areas. �Known contraindications to nerve block in suprascapular, neck and shoulder areas �Recent history of severe trauma to the suprascapular, neck and upper limb �History of suprascapular nerve block injection in the past three months �History of allergy or adverse reaction to the injecting agents �History of severe chronic airway or cardiovascular ir cerebrovascular disease �History of systemic use of steroid two weeks before the injection �Ongoing pregnancy or breastfeeding �Pain in upper limb due to conditions like osteoarthritis, rheumatoid arthritis, frozen shoulder

Design outcomes

Primary

MeasureTime frame
Primary objective: To assess pain relief (using numeric rating scale) following the suprascapular nerve block using drug mixture of 0.25% bupivacaine and 8mg dexamethasone with suprascapular nerve block using drug mixture of 0.25% bupivacaine with 4 mg dexamethasone in cervical radicular pain. Timepoint: 30 minutes after procedure 2 weeks after procedure 1 month after procedure 2 months after procedure 3 months after procedure—

Secondary

MeasureTime frame
ââ?¬Â¢To study the patientââ?¬â?¢s self reported belief about the efficacy of treatment using patient global impression of change (PGIC) scale. ââ?¬Â¢To study side effects and complications, if any. Timepoint: 2 weeks after the procedure 1 month after procedure 3 months after procedure—

Countries

India

Contacts

Public ContactDr Rishabh Anand

Pt. B.D.Sharma PGIMS Rohtak

drnaveenmalhotra@yahoo.co.in9812091051

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026